Resources from MDDCSAM’s 2018 Annual Meeting and Educational Conference
Session Name: Local, State & Federal Update: Saving Lives and Treating Addiction in Baltimore City, State of Maryland Update on Substance-related and Addictive Services, and Applying the Science of Addiction Medicine in the Context of the Opioid Epidemic - SAMHSA's Role
Presented By: Shelly Choo, MD, MPH, Senior Medical Advisor, Baltimore City Health Department, Barbara Bazron, PhD, Executive Director, Behavioral Health Administration, and Onaje Salim, EdD, LCPC, NCC, Director, Division of State and Community Assistance, Center for Substance Abuse Treatment, HHS/SAMHSA.
Session Name: Harm Reduction Approaches to the Opioid Epidemic: Innovation and Evidence
Presented By: Ju Park, PhD MHS, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health and Sharon Stancliff, MD, FASAM, Medical Consultant, New York State Department of Health, AIDS Institute.
Session Name: Office Based Buprenorphine & Naltrexone
Presented By: Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers, & Assistant Professor, Johns Hopkins University Department of Psychiatry and Megan Buresh, MD, Assistant Professor, Division of Chemical Dependence, Johns Hopkins School of Medicine.
Session Name: Medical Cannabis: Update and Impact on Addiction Treatment
Presented By: Paul Katz, DO, FACA, FASAM, Board Certified Family Practice Physician, Diplomat of the American Board of Addiction Medicine, Founder of the Chesapeake Wellness Center, & President-Elect of MDSAM, George Kolodner, MD, FASAM, DLFAPA, Medical Director, Kolmac Clinic & Clinical Professor, Georgetown University and University of Maryland Schools of Medicine, William C. Tilburg, Director, Policy & Government Affairs, Maryland Medical Cannabis Commission, and Francisco Ward, DO, DABPMR/PM, Medical Director & Founder, Seton Pain & Rehabilitation Center.
Session Name: Recent Research Greatest Hits 2017
Presented By: Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers, & Assistant Professor, Johns Hopkins University Department of Psychiatry
- View Dr. Fishman’s PowerPoint
- Article: Causes of Death After Nonfatal Opioid Overdose
- Article: Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- Article: Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder
- Article: A Randomized Controlled Study of the Efficacy of Pregabalin in the Treatment of Opiate Withdrawal Syndrome